DOI: 10.1055/s-00000030

Der Klinikarzt

References

Hecht JR, Bang YJ, Qin S et al.
Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.

J Clin Oncol 2013;
31 (Suppl. 01)

Download Bibliographical Data

Search in: